Results 201 to 210 of about 60,513 (321)
JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis.
C. Harrison +13 more
semanticscholar +1 more source
Immune thrombocytopenia in postpolythemic myelofibrosis [PDF]
Zwi A. Schreiber
openalex +1 more source
The Ongoing Challenges of Managing Cytopenic Myelofibrosis in 2025: The Emergence of Non-JAK Inhibitor Therapies. [PDF]
Reynolds SB, Komrokji R, Kuykendall AT.
europepmc +1 more source
A rare case of extramedullary hematopoiesis: when the pericardium produces blood cells. [PDF]
Hayar SE +9 more
europepmc +1 more source
Hypercalcemia and adrenal insufficiency in a patient with myelofibrosis [PDF]
Mark Hertzberg, Mark Wong
openalex +1 more source
Long‐term survival of infants with idiopathic myelofibrosis [PDF]
Rachel A. Altura +2 more
openalex +1 more source

